tiprankstipranks
Advertisement
Advertisement
Gossamer Bio Restructures Debt and Advances Seralutinib Program
PremiumCompany AnnouncementsGossamer Bio Restructures Debt and Advances Seralutinib Program
3d ago
Gossamer Bio launches exchange offer, consent solicitation
Premium
The Fly
Gossamer Bio launches exchange offer, consent solicitation
3d ago
Gossamer Bio reports Q1 EPS (20c) vs. (16c) last year
Premium
The Fly
Gossamer Bio reports Q1 EPS (20c) vs. (16c) last year
3d ago
Gossamer Bio Receives Nasdaq Minimum Bid Price Deficiency Notice
PremiumCompany AnnouncementsGossamer Bio Receives Nasdaq Minimum Bid Price Deficiency Notice
1M ago
Gossamer Bio Lawsuit: Investors Allege Misleading Statements Ahead of Failed PAH Trial 
Premium
Class Action
Gossamer Bio Lawsuit: Investors Allege Misleading Statements Ahead of Failed PAH Trial 
2M ago
Morning Movers: Apogee surges following APEX clinical trial readout
Premium
The Fly
Morning Movers: Apogee surges following APEX clinical trial readout
2M ago
Gossamer Bio reports Q4 EPS (21c), consensus (20c)
PremiumThe FlyGossamer Bio reports Q4 EPS (21c), consensus (20c)
2M ago
Stagflation Risk Is Back — These 3 Stocks Can Help Defend Your Portfolio
Premium
Market News
Stagflation Risk Is Back — These 3 Stocks Can Help Defend Your Portfolio
2M ago
Gossamer Bio options imply 46.1% move in share price post-earnings
Premium
The Fly
Gossamer Bio options imply 46.1% move in share price post-earnings
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100